Maverick Bio transforms carefully sourced animal tissues into controlled, traceable biomaterials developed for advanced medical and biotechnology applications. We develop proprietary biomaterial technologies from concept through prototyping, characterisation and preclinical development. We build the technical foundation and evidence needed to move promising technologies forward.
Looking for a particular Maverick Bio employee's phone or email?
The Maverick Bio annual revenue was $15.9 million in 2026.
Paul Broadfoot is the CEO of Maverick Bio.
30 people are employed at Maverick Bio.
Maverick Bio is based in Dubbo, New South Wales.
The NAICS codes for Maverick Bio are [32541, 325414, 325, 3254, 32].
The SIC codes for Maverick Bio are [283, 28].